
Friday, November 08, 2019 12:47:07 PM
RAPT
New York Yankees and Duke Basketball

Liked By
Spread the love. Be the first to like this post!
Recent RAPT News
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/02/2023 11:24:41 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/02/2023 11:22:23 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/02/2023 11:13:38 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/02/2023 11:09:19 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/26/2023 07:30:29 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/20/2023 11:34:11 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/17/2023 09:11:47 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/09/2023 01:04:00 PM
- RAPT Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2023 01:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 12/12/2022 09:03:57 PM
- SVB Securities Keeps Their Buy Rating on RAPT Therapeutics (RAPT) • TipRanks • 12/12/2022 11:35:26 AM
- RAPT Therapeutics Presents Update from its Phase 1/2 Clinical Trial for FLX475 as Monotherapy and in Combination with Pembrolizumab in Patients with Advanced Cancer • GlobeNewswire Inc. • 12/08/2022 11:30:00 AM
- RAPT Therapeutics to Present FLX475 Phase 1/2 Data at the European Society for Medical Oncology (ESMO) Immuno-Oncology Annual Congress • GlobeNewswire Inc. • 12/01/2022 12:05:22 AM
- Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 11/18/2022 09:53:04 PM
- RAPT Therapeutics Tanks on $75M Public Offering • TipRanks • 11/18/2022 11:39:00 AM
- RAPT Therapeutics Announces Pricing of Public Offering of Common Stock • GlobeNewswire Inc. • 11/18/2022 02:38:04 AM
- RAPT Therapeutics Announces Proposed Public Offering of Common Stock • GlobeNewswire Inc. • 11/17/2022 09:24:51 PM
- SVB Securities Keeps Their Buy Rating on RAPT Therapeutics (RAPT) • TipRanks • 11/14/2022 03:55:48 AM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/10/2022 01:22:24 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/10/2022 01:13:00 PM
- RAPT Therapeutics Reports Third Quarter 2022 Financial Results • GlobeNewswire Inc. • 11/10/2022 01:00:00 PM
- RAPT Therapeutics to Participate in Several Upcoming Investor Conferences • GlobeNewswire Inc. • 11/09/2022 01:00:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 11/03/2022 10:45:29 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 10/04/2022 04:48:02 PM
- RAPT Therapeutics Strengthens Leadership Team with Two New Key Hires • GlobeNewswire Inc. • 09/28/2022 12:00:00 PM
TNRG Signs Reg A Offering Agreement • TNRG • Feb 3, 2023 10:30 AM
Trend Innovations Holding Inc. Thy News Application Review Year 2022 and Update Toward 2023 • TREN • Feb 2, 2023 2:00 PM
Goldshore Intersects 9.46 g/t Au over 7.45m in the Southwest Zone Widths of Mineralized System Expanded Significantly. • GSHRF • Feb 2, 2023 9:58 AM
Hempacco and Snoop Dogg Create Joint Venture to Launch Consumer Goods Powerhouse of Hemp and Hemp-Derived Products • HPCO • Feb 2, 2023 9:30 AM
Kona Gold Beverage, Inc Announces Record Revenue Month in January Eclipsing Half a Million Dollars for the First Time • KGKG • Feb 2, 2023 9:00 AM
BioLife Sciences Inc. (OTC: BLFE) Announces Letter of Intent for Exclusive Licensing Deal with Canadian Firm • BLFE • Feb 2, 2023 8:32 AM